Tuesday, January 10, 2017

Rethinking pharma productivity

Many companies’ efforts to do more with less have stalled. Six situations present opportunities for executives to reignite programs that optimize efficiency and cost.
Rethinking pharma productivity

No comments:

Post a Comment